Table of Contents Table of Contents
Previous Page  60 / 536 Next Page
Information
Show Menu
Previous Page 60 / 536 Next Page
Page Background

IMAGING METHOD

PROCEDURES

COLLECTIVE EFFECTIVE DOSE

NUMBERS

%

MSV

%

Conventional radiology (dentistry excluded)

44,175,500

54.0

18,069,200

17.7

Dental radiology

27,616,000

33.8

165,700

0.2

Computed Tomography

8,484,000

10.4

72,838,900

71.3

Diagnostic interventional radiology

377,000

0.5

3,196,400

3.1

Nuclear medicine

1,103,000

1.3

7,928,300

7.8

TOTAL

81,755,500

100.0

102,198,500

100.0

TABLE 3:

Total number of procedures and associated collective effective dose for each imaging method (rounded values) in France in 2012

Source: IRSN.

Conventional radiology (54%), computed tomography

(10.5%) and dental radiology (34%) account for the

largest number of procedures. However, the contribution

of computed tomography to the effective collective dose

remains preponderant andmore significant in 2012 (71%)

than in 2007 (58%) whereas that of dental radiology

remains very low (0.2%).

To give an example, thoracic and abdominal pelvic

CT scans remain themost frequent (50% in 2012 vs 30%

in 2007), more particularly inmen after the age of 50 years

(4.2% in 2012 vs 1.4% in 2007). Women underwent

more conventional radiology procedures (mammograms

and limb examinations) than men.

In adolescents, conventional radiology and dental

proceduresaremorenumerous(1,020and1,220procedures

respectively for 1,000 individuals in 2012). Despite their

frequency in this population, dental radiology procedures

represent only 0.5% of the collective dose.

It is noteworthy that in a sample of about 600,000 persons

covered by health insurance, 44% underwent at least

one diagnostic procedure in 2012. The analysis of the

effective doses for these peoplewho effectively underwent

an examination shows that 70% of them received less

than 1 mSv, 18% received between 1 and 10 mSv, 11%

between 10 and 50mSv and 1%more than 50mSv. The

substantial uncertainties in this study with regard to

the average effective dose values per type of procedure

must nevertheless be take into account, which justifies

progressing in the dose estimates in the next exposure

study of the general population.

Particular attention is required in order to control and

reduce the doses linked to medical imaging, more

specifically when alternative techniques can be used

for a same given indication, because the multiplication

of the most heavily irradiating examinations for the

same person could lead to the effective dose value of

several tens of millisieverts being reached; at this level of

exposure, certain epidemiological surveys have revealed

the occurrence of radiation-induced cancers.

Based on a sample of 100,000 children (1% of the

French population), IRSN (2013 report) estimated that in

2010, one out of three children was exposed to ionising

radiation for diagnostic purposes. The mean andmedian

values for the effective dose are estimated at 0.65 mSv

and 0.025mSv respectively for all the children exposed.

They are 5.7 mSv and 1.7 mSv respectively for children

who have undergone at least one computed tomography

procedure (1% of the population monitored).

Controlling the doses delivered to patients remains a

priority for ASN, which has undertaken – in collaboration

with the stakeholders (institutional and professional) –

a programme of actions in various areas (quality and

safety of practices/quality assurance, human resources/

training, etc.).

3.4 Exposure of non-human species

(animal and plant species)

The international radiation protection systemwas created

to protect humans against the effects of ionising radiation.

Environmental radioactivity is thus assessedwith respect

to its impact on human beings and, in the absence of any

evidence to the contrary, it is today considered that the

current standards also protect other species.

Protection of the environment from the radiological

risk and more specifically the protection of non-human

species, must however be guaranteed independently of

the effects on humans. Pointing out that this objective

is already incorporated in the national legislation, ASN

will ensure that the impact of ionising radiation on non-

human species be effectively included in the regulations

and in the authorisations for nuclear activities as soon as

evaluation methods are available. The opinion adopted

by the GPRADE in September 2015, based on the IRSN

appraisal report, is to be published in 2016.

60

CHAPTER 01:

NUCLEAR ACTIVITIES: IONISING RADIATION AND HEALTH AND ENVIRONMENTAL RISKS

ASN report on the state of nuclear safety and radiation protection in France in 2015